Research / Sales operations research

Lead Routing Reviewer Agreement Study

A reproducible sales-operations protocol examining whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet, with explicit denominators, reviewer reliability, privacy limits, and decision boundaries.

Sales Development Rep Editorial Team · Published

Lead Routing Reviewer Agreement Study research cover

Lead Routing Reviewer Agreement Study supports only a bounded operational observation when source versions, exclusions, missingness, reviewer disagreement, sensitivity checks, and limitations remain visible.

Define the operational question

Lead Routing Reviewer Agreement Study stage 1 uses define the operational question to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-01 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 1 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-01 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Freeze governing policy versions

Lead Routing Reviewer Agreement Study stage 2 uses freeze governing policy versions to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-02 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 2 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-02 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Separate reported and verified facts

Lead Routing Reviewer Agreement Study stage 3 uses separate reported and verified facts to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-03 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 3 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-03 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Construct the preparation record

Lead Routing Reviewer Agreement Study stage 4 uses construct the preparation record to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-04 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 4 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-04 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Route incomplete or conflicting evidence

Lead Routing Reviewer Agreement Study stage 5 uses route incomplete or conflicting evidence to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-05 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 5 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-05 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Minimize prospect and account data

Lead Routing Reviewer Agreement Study stage 6 uses minimize prospect and account data to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-06 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 6 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-06 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Exercise ordinary and exception cases

Lead Routing Reviewer Agreement Study stage 7 uses exercise ordinary and exception cases to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-07 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 7 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-07 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Reconcile dependent tools

Lead Routing Reviewer Agreement Study stage 8 uses reconcile dependent tools to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-08 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 8 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-08 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Prepare the accountable-owner handoff

Lead Routing Reviewer Agreement Study stage 9 uses prepare the accountable-owner handoff to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-09 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 9 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-09 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Verify communication and receipt

Lead Routing Reviewer Agreement Study stage 10 uses verify communication and receipt to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-10 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 10 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-10 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Apply stop and rollback rules

Lead Routing Reviewer Agreement Study stage 11 uses apply stop and rollback rules to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-11 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 11 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Limitations. Lead Routing Reviewer Agreement Study stage 11 may be affected by missing events, changed policies, inconsistent clocks, selective documentation, seasonality, reviewer learning, unavailable messages, small subgroups, channel mix, and differences between sales systems. The study cannot establish causation, legal compliance, individual intent, worker performance, or a universal conversion rate. Protocol SRS-1013-03-11 requires reporting these boundaries beside the result, retaining unresolved classifications, and seeking qualified review before any operational change. Replication on a later frozen cohort is necessary before expanding the interpretation.

Retain a reviewable closure packet

Lead Routing Reviewer Agreement Study stage 12 uses retain a reviewable closure packet to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-12 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 12 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-12 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Replicate the result on a frozen follow-up cohort

Lead Routing Reviewer Agreement Study stage 13 uses replicate the result on a frozen follow-up cohort to examine whether independent reviewers assign the same bounded route when supplied the same frozen policy and evidence packet. Pre-register the eligible population, unit of analysis, observation window, frozen policy date, primary outcome, exclusions, subgroup plan, and intended operational decision before inspecting results. Retain lead key, source, account match, geography, segment, ownership rule, reviewer labels, disagreement reason, adjudication, and disposition. Protocol SRS-1013-03-13 preserves source facts separately from derived fields, reviewer classifications, adjudication, and owner actions, so a corrected final record does not erase its history or turn sales-operations evidence into an unsupported legal, privacy, performance, intent, or causal conclusion.

For Lead Routing Reviewer Agreement Study, draw the stage 13 sample from a versioned eligible-record roster and report selected, available, unavailable, excluded, transferred, reopened, unresolved, suppressed, and late records separately. Two authorized reviewers independently label a planned reliability subset using the same codebook; calculate raw agreement and category-specific disagreement before adjudication. Freeze transformations in a reproducible query or worksheet, preserve nulls, and show how the result changes under declared denominator, timing, and inclusion alternatives. Do not describe association, reviewer agreement, or workflow timing as causation or a universal sales benchmark.

Protocol SRS-1013-03-13 minimizes personal and commercially sensitive information through pseudonymous study identifiers, least-privilege access, approved source references, field-level extraction, and a named retention owner. Suppress small or identifying cells and keep credentials, unrestricted message bodies, purchased-list payloads, and sensitive account notes outside the analysis. Any response must identify the accountable revenue, legal, privacy, or compliance owner, the permitted preparation task, effective date, monitoring window, stop threshold, rollback, and follow-up review. Permission, legal basis, suppression, qualification, compensation, pricing, contracting, and exception authority remain outside the research-preparation role.

Sources

  1. FTC CAN-SPAM Act Compliance Guide
  2. FTC Telemarketing Sales Rule Compliance Guide
  3. FTC Do Not Call Provisions
  4. FCC Telemarketing and Robocalls
  5. Electronic Code of Federal Regulations Telemarketing Sales Rule
  6. Electronic Code of Federal Regulations CAN-SPAM Rule
  7. NIST Privacy Framework
  8. CISA Phishing Guidance
  9. UK ICO Direct Marketing Guidance
  10. European Commission GDPR Principles

Apply the operating question

Use the finding to define one source, output, review owner, and exception path inside a real workflow.

Discuss the workflow

Related research

Continue with the evidence.

How often do sequence enrollments lack documented approval?

A measurement design for the share of sequence enrollments that cannot be tied to a named approver, using one population, one window, and a fixed case key.

Where does account research time accumulate before first touch?

A time-segmentation method for account research, separating list intake, source verification, note writing, and review so delay is visible by stage rather than as one total.

What share of CRM hygiene exceptions clear within one business day?

A clearance-time protocol for CRM hygiene exceptions, with an explicit clock, a preserved prior value, and a close reason that separates repair from enrichment.